Hims GLP-1 Program: Compounds, Eligibility, and Dispensing

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables behind every metabolic decision. Browse all Peptides & GLP-1 education

This is an independent editorial review. PlexusDx has no commercial relationship with Hims or its parent company, and no affiliate links or compensation are involved.

Search interest in "Hims GLP-1" usually comes down to one practical question: what does the program actually put in a patient's hands, and on what terms? Hims is one of many telehealth brands operating in the GLP-1 category, and this review walks through the compounds involved, the eligibility gate, and the dispensing path — balanced editorial framing, not a buying recommendation, as of April 2026.

Hims and the GLP-1 category

Hims (Hims & Hers Health) runs on a subscription telehealth model. In programs like this, a licensed provider conducts a virtual clinical evaluation, then writes a prescription that routes to either a retail pharmacy for FDA-approved brand products or a 503A compounding pharmacy for compounded semaglutide or tirzepatide, followed by ongoing follow-up. Current program structure and pricing live on Hims's official website.

Which compounds a GLP-1 program can involve

The GLP-1 label covers more than one molecule. GLP-1 receptor agonists include semaglutide, liraglutide, and dulaglutide; tirzepatide is a GIP/GLP-1 dual agonist. Whether a given telehealth brand offers the branded product, a compounded version, or both is a program-specific detail shown at intake rather than something to assume — verify the current lineup on the brand's own site.

Eligibility and the path to dispensing

The workflow across telehealth GLP-1 programs is fairly consistent: a patient completes an intake covering weight, medical history, and current medications; a licensed clinician reviews it and, if criteria are met, issues a prescription; that prescription is fulfilled through a retail or licensed compounding pharmacy; and telehealth follow-up supports titration and side-effect management. What varies is provider type (physician versus NP or PA), pharmacy partner, and subscription tier.

What GLP-1 trials established

The pharmacology behind any legitimate GLP-1 program comes from the compound class itself. Landmark trial programs include STEP (semaglutide for weight management, The New England Journal of Medicine, 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024). Trial populations and endpoints differ, and individual outcomes vary.

The genetic layer a GLP-1 prescription skips

What a telehealth workflow does not capture is the upstream genetic architecture shaping every GLP-1 response. GLP1R, the receptor gene that is the direct target of every GLP-1 compound, sits alongside FTO (the fat-mass and obesity-associated gene), MC4R (a melanocortin receptor central to satiety), and TCF7L2 (a transcription factor tied to glucose homeostasis and GLP-1 secretion). These are pathway-level variants: they do not predict response to any specific compound, but they describe the biology a clinician is prescribing into.

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — available as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. What distinguishes the approach is the upstream genetic context. Before starting any GLP-1 pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including FTO, GLP1R, MC4R, and TCF7L2 variants that shape baseline GLP-1, appetite-regulation, and energy-balance biology. That is the test before you invest logic: turning guesswork into an informed conversation with your provider.

Not affiliated: PlexusDx has no affiliation or commercial relationship with Hims or any company named in this review.

Related reading on PlexusDx: What Is GLP 1, GLP 1 What Is, GLP 1 Receptor Agonist, GLP 1 Drugs.

Compare the PlexusDx approach: Weight Management Protocols pairs semaglutide and tirzepatide with genetic context most telehealth programs skip. Or start upstream and take the Precision Peptide Genetic Test to map your GLP-1 pathway first.

Frequently Asked Questions

What GLP-1 compounds might a Hims prescription involve?

The GLP-1 category spans receptor agonists such as semaglutide and liraglutide plus the dual agonist tirzepatide. Which specific compound, and whether it is branded or compounded, is a program-level detail shown during intake. Confirm the current offering on Hims's own site before assuming any particular molecule is available.

Does a GLP-1 program screen patients before prescribing?

Legitimate GLP-1 telehealth programs require a clinical intake and licensed-clinician review before any prescription. The evaluation covers weight, medical history, and current medications, and eligibility criteria must be met. A prescription is not automatic, and follow-up visits support dose titration and side-effect monitoring over time.

How does the Precision Peptide Genetic Test relate to a GLP-1 plan?

It does not predict how you will respond to any compound or program. Instead it reads pathway-level variants in FTO, GLP1R, MC4R, and TCF7L2 that describe your baseline GLP-1 and appetite biology — context that applies no matter which telehealth service writes the prescription or which compound is dispensed.

Where should I confirm current Hims GLP-1 pricing?

Only on the brand's own website, which publishes fees that change over time. Telehealth GLP-1 totals in this market run roughly $200 to $700+ per month as of April 2026 depending on compound, tier, and dispensing pathway. Treat any third-party figure as unverified until you check the source.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Disclaimer: This article is educational. PlexusDx is not affiliated with Hims and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols; this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.